Reverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection

Archive ouverte

Adam, Nicolas | Coutance, Guillaume | Viailly, Pierre-Julien | Drieux, Fanny | Ruminy, Philippe | Sater, Ahmad Abdel | Toquet, Claire | Rouvier, Philippe | François, Arnaud | Chenard, Marie-Pierre | Epailly, Eric | Guillemain, Romain | Pattier, Sabine | Gay, Arnaud | Varnous, Shaida | Taupin, Jean-Luc | Rabant, Marion | Loupy, Alexandre | Bruneval, Patrick | Duong van Huyen, Jean Paul

Edité par CCSD ; Elsevier -

International audience. Background: Molecular biology has emerged as a potential companion to histology for the diagnosis of rejection after heart transplantation. Reverse transcriptase multiplex ligation-dependent probe amplification (RT-MLPA) is a technique of targeted gene expression analysis suitable for formalin-fixed paraffin-embedded (FFPE) biopsies. Our aim was to assess RT-MLPA for the diagnosis of allograft rejection in heart transplantation.Methods: We performed a cross-sectional, case-control, multicenter study. After the selection of a 14-transcript panel (endothelial burden, Natural killer cells, interferon-γ pathway, effector T-cells, and antigen presentation), RT-MLPA was applied to 183 FFPE endomyocardial biopsies (EMB), randomized into a training (n = 113) and a validation (n = 70) series. A two-step class prediction analysis was developed (Linear prediction score-LPS1: rejection vs non-rejection; LPS2: antibody-mediated rejection [AMR] vs acute cellular rejection [ACR]). A study of the agreement between pathology and RT-MLPA was performed.Results: Overall, 48 ACR, 82 AMR, 5 mixed rejection, and 48 non-rejection EMBs were analyzed. Three molecular clusters were delineated by unsupervised hierarchical analysis (molecular non-rejection, ACR, and AMR). AMR was characterized by the high expression of CCL4, GNLY, FCGR3, CXCL11 and ACR by the high expression of CCL18 and ADAMdec. RT-MLPA and histopathology agreed in the final diagnosis in 82.2%, 67.7%, and 76.8% of the EMB in the test, validation, and overall cohort, respectively. Disagreement cases were more common in the case of histologic low-grade rejection and early post-transplant EMB.Conclusions: RT-MLPA is a suitable technique for targeted gene expression analysis on FFPE EMB with a good overall agreement with the histologic diagnosis of heart allograft rejection.

Suggestions

Du même auteur

Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection

Archive ouverte | Loupy, Alexandre | CCSD

International audience. Background: Antibody-mediated rejection (AMR) contributes to heart allograft loss. However, an important knowledge gap remains in terms of the pathophysiology of AMR and how detection of immu...

Correlation Between Microvascular Inflammation in Endomyocardial Biopsies and Rejection Transcripts, Donor-specific Antibodies, and Graft Dysfunction in Antibody-mediated Rejection

Archive ouverte | Coutance, Guillaume | CCSD

International audience. Background: The pathology-based diagnosis of cardiac antibody-mediated rejection (AMR) relies on the 2013 International Society for Heart and Lung Transplantation Working Formulation, in whi...

Validation of the clinical utility of microRNA as non-invasive biomarkers of cardiac allograft rejection: A prospective longitudinal multicenter study

Archive ouverte | Coutance, Guillaume | CCSD

International audience. While studies have shown an association between microRNAs and cardiac rejection, the clinical relevance of a preidentified miRNA signature as a noninvasive biomarker has never been assessed i...

Chargement des enrichissements...